Abbas Alimoradian, Saeed Pazhoohan, Omid Mirzabeygi, Kiana Naderinia,
Volume 23, Issue 6 (11-2020)
Abstract
Background and Aim: Opioid and benzodiazepine family drugs are concurrently used in various patients. Considering the respiratory depressant effects of both classes, in this study, we investigated the effect of coadministration of morphine and several widely used benzodiazepines in the clinic on the rate of respiratory depression in rats.
Methods & Materials: Seventy adult male Wistar rats were randomly divided into 10 groups; morphine, midazolam, diazepam, lorazepam, alprazolam, morphine-midazolam, morphine-diazepam, morphine-lorazepam, and morphine-alprazolam. Respiration signal was recorded using whole-body plethysmography 15 minutes after the intraperitoneal injection of the drugs. The respiratory pattern was examined using several parameters; the mean value of inter-breath interval and the respiratory rate, as well as the coefficient of variation and sample entropy analysis of inter-breath interval.
Ethical Considerations: This study was approved by the Ethics Committee of Arak University of Medical Sciences (Code: IR.ARAKMU.REC.1397.327).
Results: Analyzing respiratory data revealed that injecting the anxiolytic dose of alprazolam, and the combination of morphine-alprazolam and morphine-midazolam, altered the respiratory pattern. Such changes were associated with a decrease in the number of breaths and an increase in the inter-breath interval in the explored test animals, compared with the controls. The obtained data also indicated that morphine-midazolam injection increased the variability of the breathing pattern; such an alternation was associated with increased irregularity and decreased coefficient of variation of the inter-breath interval.
Conclusion: The present research results suggested that the short-term injection of morphine-midazolam changes the respiratory pattern more severely than morphine combined with other benzodiazepines.
Miss Homa Rastegari, Dr Davood Hekmatpou, Dr Ramiz Kamrani, Dr Moloud Farmahini Farahani,
Volume 26, Issue 1 (4-2023)
Abstract
Introduction: One of the common problems of patients with covid-19 is the occurrence of respiratory problems that may accompany the person for a long time. Also, based on clinical and research evidence, different degrees of anxiety and stress have been observed in those who have recovered from this disease. This study was conducted with the aim of determining the effect of diaphragmatic breathing on dyspnea and state anxiety in patients with covid-19.
Methods: This study was a randomized clinical trial conducted in 2021-2022. The study population consisted of 78 patients with covid-19 hospitalized in Amir al-Momenin Hospital in Arak city, who were selected by available sampling and divided into two groups of 40. In this study, the Spielberger anxiety inventory, Borg scale, MRC breathlessness scale and measurement of blood oxygen saturation were used. The test group received diaphragmatic breathing training on the day of discharge and performed the exercise for ten minutes, and after discharge, they performed diaphragmatic breathing twice a day (ten minutes each time) at home for a week. Questionnaires were completed by the patients before the intervention, immediately after and one week later. The data was analyzed with SPSS software version 23 at the level (P < 0.05).
Results: The findings showed that the mean anxiety score of the patients immediately and one week after the intervention in the test group was significantly lower than the control group (P < 0.001). The mean oxygen saturation in the test group after the intervention was significantly higher than the control group (P < 0.001). Also, a significant difference was observed between the mean dyspnea scores using the MRC and Borg dyspnea scales after the intervention in the two groups (P < 0.001).
Conclusions: The results showed diaphragmatic breathing reduced anxiety and shortness of breath in patients with covid-19 after discharge. Therefore, teaching this simple and effective method is recommended for these patients during discharge from the hospital.
